Chemed CHE Segment Vitas — Operating Income

Other segment segments

Similar metrics at other companies

BLCOVision Care — Operating Income (Loss)

$202M+14.8%

CRLSegment operating income — Operating Income (Loss)

$200.49M+55.5%

APGSpecialty Services — Operating Income (Loss)

$39M+34.5%

TMOLife Sciences Solutions — Operating Income (Loss)

$954M+14.4%

HSICGlobal Distribution And Value Added Services — Operating Income

$183M+9.6%

WSTWest Vantage — Operating Income (Loss)

$15.6M+15.6%

Questions, answered.

What is Chemed's segment vitas — operating income?

Chemed (CHE) reported segment vitas — operating income of $62.45M in Q1 2026.

How has Chemed's segment vitas — operating income changed year-over-year?

Chemed's segment vitas — operating income decreased by 0.5% year-over-year, from $62.77M to $62.45M.

What is the long-term trend for Chemed's segment vitas — operating income?

Over 3 years (2022 to 2025), Chemed's segment vitas — operating income has grown at a 16.8% compound annual growth rate (CAGR), from $155.12M to $246.94M.

What does segment vitas — operating income mean?

This metric represents the profit or loss generated from the core business operations of the segment after deducting operating expenses from segment revenues. It serves as a primary indicator of the segment's operational efficiency and its ability to generate earnings from its hospice and palliative care services.